Hoare Kishalay, Hoare Sarasija, Smith Orla M, Kalmaz Grace, Small Donald, Stratford May W
University of Florida Shands Cancer Center, 1600 SW Archer Road, Gainesville, FL 32610-0232, USA.
Oncogene. 2003 Jun 5;22(23):3562-77. doi: 10.1038/sj.onc.1206480.
Kinase of embryonic stem cells (Kos1), a nonreceptor protein tyrosine kinase (NRPTK), was identified and cloned from differentiating murine embryonic stem cells. Kos1 is localized on mouse chromosome 11 that corresponds to human chromosome 17p13.1 and is homologous to Tnk1, Ack1 and Ack2, making it a new member of the Ack family of NRPTKs. Kos1 is a ubiquitously expressed 47-kDa protein with autotyrosine kinase activity that is developmentally regulated during embryogenesis. Kos1 is also upregulated following IL3 withdrawal from factor-dependent murine NSF/N1.H7 cells that undergo apoptosis, suggesting a role in growth inhibition. Stable overexpression of Kos1 inhibits growth of NIH 3T3 cells, while the kinase-dead Kos1(CN) promotes cell growth in both liquid culture and soft agar. In addition, forced expression of Kos1 inhibits Ras activity in an indirect mechanism that results in the downregulation of the Ras-Raf1-MAPK growth pathway. Furthermore, overexpression of Kos1 in NCI-H82 lung cancer cells that express oncogenic Ha-Ras(G12V) inhibits cell growth under reduced serum (0.5%) conditions in close association with the upregulation of the Ras inhibitor, Rap1A. Collectively, these data support a negative regulatory role for Kos1 in regulating the Ras-Raf1-MAPK growth pathway by a mechanism that requires its autotyrosine kinase activity.
胚胎干细胞激酶(Kos1)是一种非受体蛋白酪氨酸激酶(NRPTK),从分化的小鼠胚胎干细胞中被鉴定并克隆出来。Kos1定位于小鼠11号染色体,该染色体对应于人类17号染色体p13.1区域,并且与Tnk1、Ack1和Ack2同源,这使其成为NRPTK的Ack家族的新成员。Kos1是一种普遍表达的47 kDa蛋白,具有自身酪氨酸激酶活性,在胚胎发育过程中受到发育调控。在依赖因子的小鼠NSF/N1.H7细胞中,撤除IL3后细胞发生凋亡,此时Kos1也会上调,提示其在生长抑制中发挥作用。Kos1的稳定过表达抑制NIH 3T3细胞的生长,而激酶失活的Kos1(CN)在液体培养和软琼脂中均促进细胞生长。此外,Kos1的强制表达通过间接机制抑制Ras活性,导致Ras-Raf1-MAPK生长途径下调。此外,在表达致癌性Ha-Ras(G12V)的NCI-H82肺癌细胞中过表达Kos1,在血清减少(0.5%)的条件下抑制细胞生长,这与Ras抑制剂Rap1A的上调密切相关。总的来说,这些数据支持Kos1在通过一种需要其自身酪氨酸激酶活性的机制调节Ras-Raf1-MAPK生长途径中发挥负调控作用。